Completed
Phase 3
Age: 30Years - 74Years
All Genders
ID00000565
Led by National Heart, Lung, and Blood Institute (NHLBI) · Updated on 2016-04-14
N/A
Participants Needed
N/A
Research Sites
N/A
Total Duration
On this page
AI-Summary
What this Trial Is About
To evaluate the efficacy of long-term intermittent positive pressure breathing (IPPB) treatment when used as an adjunct to the overall care of ambulatory outpatients with chronic obstructive pulmonary disease. The evaluation compared the use of IPPB with use of a powered nebulizer.
CONDITIONS
Official Title
Clinical Study of Intermittent Positive Pressure Breathing (IPPB)
Who Can Participate
Age: 30Years - 74Years
All Genders
Eligibility Criteria
You may qualify if you...
Men and women, ages 30 to 74, who were ambulatory and had symptomatic chronic bronchitis or emphysema.
You will not qualify if you...
History of severe allergic reactions to study medication Currently pregnant or breastfeeding Recent participation in another clinical trial within the last 30 days Presence of uncontrolled medical conditions that could affect safety
Trial Site Locations
Site Locations not provided
Location information for this trial is currently unavailable.
How is the study designed?
Study Type
INTERVENTIONAL
Masking
N/A
Allocation
RANDOMIZED
Model
N/A
Primary Purpose
TREATMENT
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Published Research Related To This Trial
Neuropsychological test performance in mildly hypoxemic patients with chronic obstructive pulmonary disease.
G P Prigatano, O Parsons, E Wright...
https://pubmed.ncbi.nlm.nih.gov/6826857Quality of life and its predictors in patients with mild hypoxemia and chronic obstructive pulmonary disease.
G P Prigatano, E C Wright, D Levin
https://pubmed.ncbi.nlm.nih.gov/6380440The National Institutes of Health Intermittent Positive-Pressure Breathing trial: pathology studies. I. Interrelationship between morphologic lesions.
A Nagai, W W West, J L Paul...
https://pubmed.ncbi.nlm.nih.gov/3904548The National Institutes of Health Intermittent Positive-Pressure Breathing trial: pathology studies. II. Correlation between morphologic findings, clinical findings, and evidence of expiratory air-flow obstruction.
A Nagai, W W West, W M Thurlbeck
https://pubmed.ncbi.nlm.nih.gov/3904549The National Institutes of Health Intermittent Positive Pressure Breathing trial--pathology studies. III. The diagnosis of emphysema.
W W West, A Nagai, J E Hodgkin...
https://pubmed.ncbi.nlm.nih.gov/3541712Body weight in chronic obstructive pulmonary disease. The National Institutes of Health Intermittent Positive-Pressure Breathing Trial.
D O Wilson, R M Rogers, E C Wright...
https://pubmed.ncbi.nlm.nih.gov/2658702The National Institutes of Health Intermittent Positive-Pressure Breathing Trial: pathology studies. IV. The Destructive index.
K Matsuba, T Ikeda, A Nagai...
https://pubmed.ncbi.nlm.nih.gov/2658703